Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingyun Koh

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Cureus|June 11, 2026
Moving Toward Hepatitis C Elimination in Haemodialysis: HCV Antigen as a Practical Screening AlternativeSamantha Jingyun Koh, Wei Lun Liou, Sheryl Gan, et al.
Plos Pathogens|January 31, 2009
Local inflammation induces complement crosstalk which amplifies the antimicrobial responseJing Zhang, Jingyun Koh, Jinhua Lu, et al.
Endoscopy International Open|June 12, 2020
Impact of enhanced personal protective equipment on colonoscopy performance during the COVID-19 pandemicKevin Kim Jun Teh, Shu Wen Tay, Kaina Chen, et al.
Journal of Gastroenterology and Hepatology|November 20, 2020
Efficacy and safety of sofosbuvir/velpatasvir in a real-world chronic hepatitis C genotype 3 cohortYu Jun Wong, Prem Harichander Thurairajah, Rahul Kumar, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Cureus|June 11, 2026
Moving Toward Hepatitis C Elimination in Haemodialysis: HCV Antigen as a Practical Screening AlternativeSamantha Jingyun Koh, Wei Lun Liou, Sheryl Gan, et al.
Plos Pathogens|January 31, 2009
Local inflammation induces complement crosstalk which amplifies the antimicrobial responseJing Zhang, Jingyun Koh, Jinhua Lu, et al.
Endoscopy International Open|June 12, 2020
Impact of enhanced personal protective equipment on colonoscopy performance during the COVID-19 pandemicKevin Kim Jun Teh, Shu Wen Tay, Kaina Chen, et al.
Journal of Gastroenterology and Hepatology|November 20, 2020
Efficacy and safety of sofosbuvir/velpatasvir in a real-world chronic hepatitis C genotype 3 cohortYu Jun Wong, Prem Harichander Thurairajah, Rahul Kumar, et al.
Pageof 1